JPS5843389B2 - Method for measuring collagenase activity using peptide nodule and peptide derivative - Google Patents

Method for measuring collagenase activity using peptide nodule and peptide derivative

Info

Publication number
JPS5843389B2
JPS5843389B2 JP10350576A JP10350576A JPS5843389B2 JP S5843389 B2 JPS5843389 B2 JP S5843389B2 JP 10350576 A JP10350576 A JP 10350576A JP 10350576 A JP10350576 A JP 10350576A JP S5843389 B2 JPS5843389 B2 JP S5843389B2
Authority
JP
Japan
Prior art keywords
added
gly
ether
peptide
under reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10350576A
Other languages
Japanese (ja)
Other versions
JPS5328165A (en
Inventor
裕 永井
隆弘 堺
俊平 榊原
研司 藤原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP10350576A priority Critical patent/JPS5843389B2/en
Priority to SE7700582A priority patent/SE431201B/en
Priority to US05/761,020 priority patent/US4138394A/en
Priority to DE19772702699 priority patent/DE2702699A1/en
Priority to US05/853,302 priority patent/US4176009A/en
Publication of JPS5328165A publication Critical patent/JPS5328165A/en
Publication of JPS5843389B2 publication Critical patent/JPS5843389B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】 本発明は新規ペプチド誘導体ならびにそれを用いるコラ
ゲナーゼ活性の測定法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel peptide derivative and a method for measuring collagenase activity using the same.

更に詳しくは、コラゲナーゼに対する特異基質として有
用な新規オクタペプチド誘導体に関し、有用な本ペプチ
ド遊導体およびそれを用いるコラゲナーゼ活性の測定方
法を提供するものである。
More specifically, the present invention relates to a novel octapeptide derivative useful as a specific substrate for collagenase, and provides a useful peptide derivative of the present invention and a method for measuring collagenase activity using the same.

近年、コラーゲンおよびそれを分解する酵素コラゲナー
ゼに関する研究が活発に行われ、結合織の病変が関与す
る疾患、例えば各種皮膚疾患、創傷、全身紅斑狼癒、胃
潰瘍の胃粘膜、角膜潰瘍、肝硬変、線維肉腫等の組織、
リウマチ性関節炎の滑液、更に本態性高血正症、動脈硬
化症、糖尿病等の患者の顆粒白血球等に含まれるコラゲ
ナーゼが著名に変動している現象が発見された。
In recent years, research on collagen and the enzyme collagenase that decomposes it has been actively conducted, and it has been used to treat diseases involving connective tissue lesions, such as various skin diseases, wounds, systemic erythema lupus, gastric mucosa of gastric ulcers, corneal ulcers, liver cirrhosis, and fibrosis. Tissues such as sarcoma,
It has been discovered that collagenase contained in the synovial fluid of rheumatoid arthritis, as well as granular leukocytes of patients with essential hyperemia, arteriosclerosis, diabetes, etc., fluctuates significantly.

また、発見者らの研究により、肝硬変、肝疾患の一部に
あってはその血清中のコラゲナーゼ活性が上昇している
ことが認められた。
In addition, research by the discoverers has revealed that collagenase activity in the serum of some patients with liver cirrhosis and other liver diseases is increased.

従って、上記疾患ならびに関連疾患の診断上、生体のコ
ラゲナーゼ活性を測定することは重要な意義を有するの
である。
Therefore, in diagnosing the above-mentioned diseases and related diseases, it is of great significance to measure collagenase activity in living organisms.

従来のコラゲナーゼ活性の測定は、天然のコラーゲン、
例えば動物の皮膚、鍵等より抽出したコラーゲンを基質
として、測定さるべきコラゲナーゼ標品を作用せしめ、
その分解率を求める方法にて行われてきた。
Conventional collagenase activity measurements are performed using natural collagen,
For example, a collagenase preparation to be measured is applied to collagen extracted from animal skin, keys, etc. as a substrate,
This method has been used to determine the decomposition rate.

この方法では、■天然コラーゲンの分子量がきわめて大
きく、且つ広い分子量分布をもち、一定の分子量のもの
を得ることは極めて困難であり、且つその抽出操作は極
めて繁雑である。
In this method, (1) the molecular weight of natural collagen is extremely large and has a wide molecular weight distribution; it is extremely difficult to obtain collagen with a constant molecular weight; and the extraction operation is extremely complicated.

■コラーゲンを抽出する動物の種類、部位によりコラー
ゲンの性質が一定していないこと、さらに■生体内コラ
ゲナーゼ活性を測定する際、測定試料に血清蛋白質のa
2−マクログロブリンの混入がさけられないのであるが
、このa2−マクログロブリンは天然コラーゲンを基質
としてコラゲナーゼ活性を測定する場合阻害物質として
作用する、などにより精密なコラゲナーゼ活性の測定法
としては適切なものでなかった。
■ The properties of collagen are not constant depending on the type and site of the animal from which collagen is extracted. Furthermore, ■ When measuring in vivo collagenase activity, serum protein a.
Although contamination with 2-macroglobulin cannot be avoided, this a2-macroglobulin acts as an inhibitor when measuring collagenase activity using natural collagen as a substrate. It was nothing.

上記第3の欠点を回避するために、コラゲナーゼa2−
マクログロブリン等の阻害物質結合体を予めロダンナト
リウム等にて処理することにより、コラゲナーゼの活性
を復活させる試みがなされたが、副反応が起り測定値の
変動が大きく、実用的な正確度を期し難い。
In order to avoid the third drawback mentioned above, collagenase a2-
Attempts have been made to restore collagenase activity by pre-treating inhibitory substance conjugates such as macroglobulin with rhodan sodium, etc., but side reactions occur and the measured values fluctuate greatly, making it difficult to achieve practical accuracy. hard.

従って、簡便で精密なコラゲナーゼ活性の測定法の確立
が待望されてきた。
Therefore, there has been a long-awaited establishment of a simple and accurate method for measuring collagenase activity.

本発明者らは、適当なペプチドを合或し天然コラーゲン
のモデル物質として基質に使用することにより、従来法
の欠点を克服できると考え、コラゲナーゼが特異的に切
断するペプチド結合の位置およびコラゲナーゼ、基質両
者間の特異性に関し鋭意研究した。
The present inventors believe that the shortcomings of conventional methods can be overcome by using an appropriate peptide as a substrate or as a model substance of natural collagen. We conducted extensive research on the specificity between the two substrates.

その結果、基質特異性を高度に保有し、しかもコラゲナ
ーゼ活性測定に於いて操作上特に有利なコラーゲンのモ
デル物質たる新規オクタペプチド誘導体を完成した。
As a result, we have completed a novel octapeptide derivative that is a collagen model substance that has a high degree of substrate specificity and is particularly advantageous in terms of operation in measuring collagenase activity.

更に本オクタペプチド誘導体は先述した血清蛋白質のa
2−マクログロブリンによる阻害を全く受けることなく
、コラゲナーゼ活性を発現させ得るという優れた特徴を
有するものであることが認められた。
Furthermore, this octapeptide derivative has the above-mentioned serum protein a.
It was recognized that it has the excellent feature of being able to express collagenase activity without being inhibited by 2-macroglobulin at all.

しかも、本オクタペプチド誘導体、特にその発色用基間
は安定で光に対しても分解することなく長期保存が可能
である。
Moreover, the present octapeptide derivative, especially its color-forming group, is stable and can be stored for a long period of time without being decomposed by light.

即ち、本発明は、一般式 %式% ((但し、Xはp−(4−ヒドロキシ−1−ナフチルア
ゾ)ベンゼンスルホニル基またはp−フェニルアゾベン
ゾイル基を、OHはC−末端が遊離カルボキシル基であ
ることを、Pro、Gin、Gly。
That is, the present invention has the following formula: Pro, Gin, Gly.

11e、AlaおよびArgはそれぞれプロリン、グル
タミン、グリシン、インロイシン、アラニンおよびアル
ギニン単位を示す。
11e, Ala and Arg represent proline, glutamine, glycine, inleucine, alanine and arginine units, respectively.

))で示されるペプチド誘導体およびそれを用いるコラ
ゲナーゼ活性の測定法である。
)) and a method for measuring collagenase activity using the same.

上記オクタペプチド誘導体はコラゲナーゼを作用せしめ
ると、疎水性を有するトリペプチド誘導体; X−L
−Pro−L−Gln−Gly −OHを遊離する。
When the above-mentioned octapeptide derivative is treated with collagenase, it becomes a tripeptide derivative having hydrophobicity;
-Pro-L-Gln-Gly-OH is released.

このトリペプチド誘導体は疎水性であるので適当な有機
溶媒、例えば酢酸エチル、エーテル、n−ブタノール等
によって容易且つ充分に抽出され、しかも発色団基間を
有するので抽出液を通常の比色定量等の光学手段を用い
て正確に定量することができる。
Since this tripeptide derivative is hydrophobic, it can be extracted easily and sufficiently with a suitable organic solvent such as ethyl acetate, ether, n-butanol, etc. Furthermore, since it has a chromophore group, the extract can be extracted using conventional colorimetric methods. can be accurately quantified using optical means.

抽出に当っては本トリペプチド誘導体のみ抽出し、比色
定量領域に吸収を有するコラゲナーゼ含有試料中の他物
質は抽出しないことがコラゲナーゼ活性測定の精度上重
要であるが、他物質を抽出しない点で酢酸エチルが好ま
しい。
During extraction, it is important for the accuracy of collagenase activity measurement to extract only this tripeptide derivative and not to extract other substances in the collagenase-containing sample that have absorption in the colorimetric region. and ethyl acetate is preferred.

本トリペプチド誘導体は好適な酢酸エチルにて充分抽出
されるのである。
This tripeptide derivative can be sufficiently extracted with suitable ethyl acetate.

従って、本オクタペプチド誘導体を基質として用いるこ
とにより正確にしかも極めて簡便にコラゲナーゼ活性を
求めることができる。
Therefore, by using this octapeptide derivative as a substrate, collagenase activity can be determined accurately and extremely easily.

本発明(ご、゛係る新規ペプチド誘導体はペプチド化学
に於いてよく知られている方法により製造することがで
きる。
According to the present invention, such novel peptide derivatives can be produced by methods well known in peptide chemistry.

即ち一般式%式% (但し、Yはアルギニン単位のグアニジノ基の保護基を
、Rはアルギニン単位のカルボキシル基の保護基を示す
That is, the general formula % formula % (However, Y represents a protecting group for the guanidino group of the arginine unit, and R represents a protective group for the carboxyl group of the arginine unit.

)で示される保護ペプチド誘導体を脱保護することによ
り通常得ることができる。
) can usually be obtained by deprotecting the protected peptide derivative shown in ().

アルギニン単位のグアニジノ基の保護基Yとしてハトシ
ル基(p−t−ルエンスルホニル基)、ニトロ基、ベン
ジルオキシカルボニル基、p−ニトロベンジルオキシカ
ルボニル基%2−(イソプロピルオキシカルボニル)−
3,4,5,6−チトラクロルベンゾイル基等公知の保
護基でよ<、特に前三者が通虐好ましく用いられる。
As the protecting group Y for the guanidino group of the arginine unit, a hatosyl group (pt-luenesulfonyl group), a nitro group, a benzyloxycarbonyl group, a p-nitrobenzyloxycarbonyl group%2-(isopropyloxycarbonyl)-
Known protective groups such as 3,4,5,6-titrachlorobenzoyl group are commonly used, and the first three are generally preferred.

一方、アルギニン単位のカルボキシル基の保護としては
、ペプチド化学で譜用されているエステル類に変換する
ことにより行われる。
On the other hand, the protection of the carboxyl group of the arginine unit is carried out by converting it to esters commonly used in peptide chemistry.

即ち、保護基Rとしてはベンシル、t−ブチル、p−ニ
トロベンジル、p−メトキシベンジル基、特にベンジル
基、t−ブチル基が好ましく用いられる。
That is, as the protecting group R, benzyl, t-butyl, p-nitrobenzyl, p-methoxybenzyl groups, particularly benzyl group and t-butyl group are preferably used.

保護基の脱離方法にあっても個々の保護基に応じ適宜公
知方法を選択すればよいが、その際発色団基X等地の構
成単位が同時に脱離或いは変化することは許されない。
Regarding the method of removing the protecting group, a known method may be selected as appropriate depending on the individual protecting group, but in this case, simultaneous removal or change of the constituent units such as the chromophore group X is not allowed.

従って、両保護基を選択的に脱離せしめる脱離方法を、
的に保護基および発色団基に応じ選定することが肝要で
ある。
Therefore, the elimination method that selectively eliminates both protecting groups is
It is important to select the protective group and chromophore group accordingly.

脱離方法としては弗化水素処理が、両保護基を同時に脱
離することができるので好ましく用いられる。
As the elimination method, hydrogen fluoride treatment is preferably used since both protecting groups can be eliminated at the same time.

弗化水素で脱保護のために用いる場合、一般には無水の
状態で使用される。
When used for deprotection with hydrogen fluoride, it is generally used in an anhydrous state.

反応は溶媒の存在下にも、非存在下にも行いうるが、通
常弗化水素を溶媒的に使用して行われる。
Although the reaction can be carried out in the presence or absence of a solvent, it is usually carried out using hydrogen fluoride as a solvent.

また、副反応を抑制するため、少量のアニソール、フェ
ノール等の共存下に反応を行うのが好ましい。
Further, in order to suppress side reactions, it is preferable to carry out the reaction in the presence of a small amount of anisole, phenol, etc.

反応温度は一70°〜20℃、好ましくは−lO°〜l
O℃程度である。
The reaction temperature is -70° to 20°C, preferably -lO° to l
It is about 0°C.

反応終了後、自体公知の手段で目的物を取得することが
できる。
After the reaction is completed, the target product can be obtained by means known per se.

出発物質たる保護ペプチド誘導体はペプチド化学で常用
されている方法により合成することができる。
The protected peptide derivative as a starting material can be synthesized by methods commonly used in peptide chemistry.

具体的には、発色団基間にて修飾されたL−プロリンを
初めとする保護アミノ酸を順次固相、或いは液相にてペ
プチド縮合せしめる(所謂、Stepwise Elo
ngation)、或いは適当なフラグメント、例えば
X = L −Pro−L−Gin−Gly−OHとア
ルギニン単位のグアニジノ基およびカルボキシル基を保
護したL−I 1e−L−Ala−Gly−A〒g(Y
)−oRを予め合成し、次いで各フラグメントをウォー
ターソルブルカルボジイミド(エチルN、N−ジメチル
アミノプロピルカルボジイミドまたはその塩等)などの
縮合剤を用い、または活性エステル化法など他の縮合方
法によりペプチド誘導体は得ることができる。
Specifically, protected amino acids such as L-proline modified between chromophore groups are sequentially peptide-condensed in a solid phase or a liquid phase (so-called Stepwise Elo
ngation), or a suitable fragment, such as L-I 1e-L-Ala-Gly-A〒g(Y
)-oR is synthesized in advance, and then each fragment is synthesized into a peptide using a condensing agent such as a water-soluble carbodiimide (ethyl N, N-dimethylaminopropylcarbodiimide or a salt thereof, etc.) or by other condensation methods such as an active esterification method. Derivatives can be obtained.

発色団基は上記した如くL−プロリンに導入して後縮合
反応に供してもよいが、L−プロリンのN−末端を通常
のアミノ保護基、例えばt−ブチルオキシカルボニル、
ベンジルオキシカルボニル、t−アミルオキシカルボニ
ル等で保護し縮合反応に供して後、合成途上のフラグメ
ントの段階にて、或いは最終段階にて轟該アミノ保護基
を発色団基に置換してもよい。
Although the chromophore group may be introduced into L-proline and subjected to the post-condensation reaction as described above, the N-terminus of L-proline may be substituted with a conventional amino protecting group, such as t-butyloxycarbonyl,
After protection with benzyloxycarbonyl, t-amyloxycarbonyl, etc. and subjecting to condensation reaction, the amino protecting group may be substituted with a chromophore group in the fragment stage during synthesis or in the final stage.

本発明に係るペプチド誘導体を用いてコラゲナーゼ活性
を測定する方法は、天然のコラーゲンを基質に用いる場
合とはゾ同一である。
The method for measuring collagenase activity using the peptide derivative according to the present invention is the same as when using natural collagen as a substrate.

即ち、まず初めに当該オクタペプチド誘導体の一定濃度
水性溶液を調製する。
That is, first, an aqueous solution of the octapeptide derivative at a constant concentration is prepared.

この基質溶液ははゾ中性領域、より詳しくは約pH6〜
9、特にpH7〜8に調整され、測定に供される。
This substrate solution is in the neutral region, more specifically at a pH of about 6~
9, particularly adjusted to pH 7 to 8, and subjected to measurement.

本オクタペプチド誘導体のうち、X−h’ p −(4
−ヒドロキシ−1−ナフチルアゾ)ベンゼンスルフォニ
ル基のものは、溶解度が充分でない場合がある。
Among the present octapeptide derivatives, X-h' p -(4
-Hydroxy-1-naphthylazo)benzenesulfonyl groups may not have sufficient solubility.

その様な時はアルコール、例えばエチルアルコールを添
加し溶解を促進せしめ使用する。
In such cases, alcohol, such as ethyl alcohol, is added to promote dissolution.

測定は、前記基質溶液にコラゲナーゼ含有試料を300
〜45℃、好ましくは35°〜40℃にて接触、作用せ
しめ、基質および酵素量に応じ適当な時間反応させた後
、塩酸を加えるなどして酵素を失活せしめる。
In the measurement, a collagenase-containing sample was added to the substrate solution at 300%
After contacting and reacting at ~45°C, preferably 35°~40°C, and reacting for an appropriate time depending on the substrate and enzyme amount, the enzyme is deactivated by adding hydrochloric acid or the like.

酵素作用により遊離生成するX−L−Pro−L−Gl
n−Gly−OHが放出されるが、酢酸エチル、エーテ
ル、n−ブタノールまたはこれらの混合溶媒等の適当な
有機溶媒にてこれを抽出し、使用発色団基に応じ最も有
利な波長を用い、例えばXがp−(4−ヒドロキシ−1
−ナフチルアゾ)ベンゼンスルフォニル基ならば389
nm。
X-L-Pro-L-Gl produced freely by enzymatic action
n-Gly-OH is released, which is extracted with a suitable organic solvent such as ethyl acetate, ether, n-butanol or a mixture thereof, using the most advantageous wavelength depending on the chromophore group used. For example, if X is p-(4-hydroxy-1
-Naphthylazo)benzenesulfonyl group is 389
nm.

p−フェニルアゾベンゾイル基ならば325 nmにて
吸光度を測定する。
If it is a p-phenylazobenzoyl group, the absorbance is measured at 325 nm.

本オクタペプチド誘導体は極めて高度に基質特異性を有
するものであるから、通常のコラゲナーゼ含有試料、例
えば血精等にあってはこのオクタペプチド誘導体を基質
とする測定にて充分精度よくコラゲナーゼ活性は求める
ことができるが、肝臓、腎臓等の組織からのコラゲナー
ゼ試料の如く他の非特異的ペプチダーゼ活性の特に強い
試料にあっては、前記オクタペプチド誘導体の加水分解
が一部起り、コラゲナーゼ活性の精密測定には不十分な
場合があることが判明した。
Since this octapeptide derivative has extremely high substrate specificity, collagenase activity can be determined with sufficient accuracy in ordinary collagenase-containing samples, such as blood sperm, by measurement using this octapeptide derivative as a substrate. However, in samples with particularly strong non-specific peptidase activity, such as collagenase samples from tissues such as liver and kidney, some of the octapeptide derivatives may be hydrolyzed, making it difficult to precisely measure collagenase activity. It turns out that there are cases where this is insufficient.

そこで、この様な場合にも充分精度よく測定するにはコ
ラゲナーゼには不活性であるが、コラゲナーゼ含有試料
に随伴することの多い他の非特異的ペプチダーゼにより
加水分解を受けるペプチド誘導体に関し更に研究した結
果、上記オクタペプチド誘導体よりプロリン残基の欠如
した新規へブタペプチド誘導体がこれら条件を充たすこ
とを見い出した。
Therefore, in order to perform measurements with sufficient accuracy even in such cases, we conducted further research on peptide derivatives that are inactive to collagenase but undergo hydrolysis by other nonspecific peptidases that are often associated with collagenase-containing samples. As a result, it was found that a new hepatopeptidyl peptide derivative, which lacks a proline residue compared to the above-mentioned octapeptide derivative, satisfies these conditions.

この場合には、プロリン残基の欠如したヘプタペプチド
誘導体を用い次の如く測定は行れる。
In this case, the measurement can be performed as follows using a heptapeptide derivative lacking a proline residue.

即ち、使用したオクタペプチド誘導体と同一の発色団基
Xを有するヘプタペプチド誘導体の同一モル濃度、同一
溶媒の対照基質溶液を調製する。
That is, a control substrate solution of a heptapeptide derivative having the same chromophore group X as the octapeptide derivative used, the same molar concentration, and the same solvent is prepared.

全く同一条件にて同量の試料を当該基質溶液に作用せし
めて後、放出された発色団基含有分解生成物を同様に抽
出し、同一波長により吸光度を測定する。
After the same amount of sample is allowed to act on the substrate solution under exactly the same conditions, the released chromophore group-containing decomposition product is similarly extracted and the absorbance is measured at the same wavelength.

次いでオクタペプチド誘導体の場合の吸光度より対照実
験の吸光度を差し引くことにより試料中のコラゲナーゼ
活性が、試料中の他の非特異的ペプチダーゼによる影響
を受けることなく、高度に精密に求められるのである。
By subtracting the absorbance of the control experiment from the absorbance of the octapeptide derivative, the collagenase activity in the sample can be determined with high precision, without being influenced by other non-specific peptidases in the sample.

以上の説明にて明らかなとおり本発明は、医学特に診断
の分野に於いて重要な意義を有するコラゲナーゼ活性の
測定に極めて有利に用いることができる新規ペプチド誘
導体およびそれを用いるコラゲナーゼ活性の測定方法を
提供するものである。
As is clear from the above description, the present invention provides a novel peptide derivative that can be extremely advantageously used for measuring collagenase activity, which has important significance in the field of medicine, especially diagnosis, and a method for measuring collagenase activity using the same. This is what we provide.

以下、実施例により本発明の詳細な説明する。Hereinafter, the present invention will be explained in detail with reference to Examples.

なお実施例中の各略号は夫々次の意味を有する。Note that each abbreviation in the examples has the following meaning.

BOC:t−ブチルオキシカルボニル基、Z:ベンジル
オキシカルボニル基、NABS : p−(ヒドロキシ
−■−ナフチルアゾ)ベンゼンスルフォニル基、PAB
: p−フェニルアゾベンゾイル基、Bzl:ベンジル
基、Et:エチル基、TosOH: p−トルエンスル
ホン酸、WSCI:エチルーN、N−ジメチルアミノプ
ロピルカルボジイミド THF :テヘ トラヒドロフラン、DMFニジメチルホルムアミド、 また実施例3および4にて用いた精製コラゲナーゼはY
、Nagal et al (B ioche
m。
BOC: t-butyloxycarbonyl group, Z: benzyloxycarbonyl group, NABS: p-(hydroxy-■-naphthylazo)benzenesulfonyl group, PAB
: p-phenylazobenzoyl group, Bzl: benzyl group, Et: ethyl group, TosOH: p-toluenesulfonic acid, WSCI: ethyl-N,N-dimethylaminopropylcarbodiimide THF: Tehetrahydrofuran, DMF dimethylformamide, and The purified collagenase used in Examples 3 and 4 was Y
, Nagal et al.
m.

Biophys、Acta 、 263,564 (
1972))の方法により得たものである。
Biophys, Acta, 263,564 (
1972)).

実施例 I NABS−L−Pro−L−Gln−Gly−L−Il
e−Ala−Gly−L−Gln −D−Arg −O
Hの合成1)Boc−L−Pro−L−Gin−Gly
−OBzlの合成Boc−L−Gln−Gly−oBz
l (11,8,9,0,03mol)に冷却下トリフ
ルオロ酢酸(30−)を加えた後、室温で2時間攪拌し
た。
Example I NABS-L-Pro-L-Gln-Gly-L-Il
e-Ala-Gly-L-Gln-D-Arg-O
Synthesis of H 1) Boc-L-Pro-L-Gin-Gly
-Synthesis of OBzl Boc-L-Gln-Gly-oBz
After adding trifluoroacetic acid (30-) to L (11,8,9,0,03 mol) under cooling, the mixture was stirred at room temperature for 2 hours.

薄層クロマトグラフィーで反応が終了したのを確認した
後、減圧下にトリフルオロ酢酸を留去し、残渣にエーテ
ルを加えて混練して固体にし、エーテルはデカントして
除いた。
After confirming the completion of the reaction by thin layer chromatography, trifluoroacetic acid was distilled off under reduced pressure, ether was added to the residue and kneaded to form a solid, and the ether was removed by decantation.

同様の操作を2回繰り返した後、固体は水酸化ナトリウ
ム上減圧下に乾燥した。
After repeating the same operation twice, the solid was dried under reduced pressure over sodium hydroxide.

この固体をlO〇−のTHFに溶解し、Boc−L−P
ro −OH(6,5g、 0.03 mol )、l
−ヒドロキシベンット1ごアソ゛−ル(4,9g。
This solid was dissolved in lO〇- THF and Boc-L-P
ro-OH (6.5 g, 0.03 mol), l
-Hydroxybent 1 assol (4.9g).

0.036 mol )を加え、冷却下にWSCI (
6,6ml 、 0.036mol )を加え、 その
まま1時間攪拌した。
0.036 mol) was added and WSCI (0.036 mol) was added under cooling.
6.6 ml, 0.036 mol) was added thereto, and the mixture was stirred for 1 hour.

その後、室温で1夜攪拌した。反応液を減圧下に濃縮し
、残渣にクロロホルムを加えて溶解し、クロロホルム層
を、水、IN塩酸、水、5%炭酸水素ナトリウム水溶液
、水、飽和食塩水の順に洗浄した後、芒硝で乾燥した。
Thereafter, the mixture was stirred at room temperature overnight. The reaction solution was concentrated under reduced pressure, chloroform was added to the residue to dissolve it, and the chloroform layer was washed successively with water, IN hydrochloric acid, water, 5% aqueous sodium bicarbonate solution, water, and saturated brine, and then dried with sodium sulfate. did.

芒硝を除いた後、クロロホルムを減圧下に留去し、残渣
にヘキサンを加えて固体を得た。
After removing Glauber's salt, chloroform was distilled off under reduced pressure, and hexane was added to the residue to obtain a solid.

メタノール−エーテルより再結晶した。It was recrystallized from methanol-ether.

2)Boc−L−Pro−L−Gln−Gly−OHの
合成りoc−L−Pro−L−Gin−Gly−OBz
l(4,0El 、 8.2 mmol )を90%メ
タノール水溶液(60mのに溶解し、Pd−大さじ1杯
加え、水素ガスを6時間通じた。
2) Synthesis of Boc-L-Pro-L-Gln-Gly-OH oc-L-Pro-L-Gin-Gly-OBz
1 (4.0 El, 8.2 mmol) was dissolved in a 90% methanol aqueous solution (60 m), 1 tablespoon of Pd was added, and hydrogen gas was bubbled through for 6 hours.

薄層クロマトグラフィーで反応が終了したのを確認した
後、反応液を濾過して触媒を除き濾液は、減圧下に濃縮
乾固した。
After confirming the completion of the reaction by thin layer chromatography, the reaction solution was filtered to remove the catalyst, and the filtrate was concentrated to dryness under reduced pressure.

残渣にエーテルを加えて固体を得た。メタノール−エー
テルから再結晶した。
Ether was added to the residue to obtain a solid. Recrystallized from methanol-ether.

収量2.9g(91%) 3) D−krg (NO2) −0B z 1 ・
2T osOHの合成H,Gibian et al
(Liebigs Ann。
Yield 2.9g (91%) 3) D-krg (NO2) -0B z 1 ・
Synthesis of 2T osOH H, Gibian et al.
(Liebigs Ann.

Chem、、642,145(1962)”]の方法に
より得たD−Arg (NO2X 16.4 ’l 、
75mmol)、p−トルエンスルホン酸(31,4
g、165mmol)、ベンジルアルコール(37mA
りをクロロホルム(150d)に懸濁し、5時間還流し
均一溶液を得た。
D-Arg (NO2X 16.4'l,
75 mmol), p-toluenesulfonic acid (31,4
g, 165 mmol), benzyl alcohol (37 mA
The suspension was suspended in chloroform (150d) and refluxed for 5 hours to obtain a homogeneous solution.

上記均一溶液にトルエン(iooi)を加え減EE濃縮
し、更にクロロホルム(150rrLl)ヲ加え5時間
還流した。
Toluene (iooi) was added to the above homogeneous solution, and the mixture was concentrated under reduced EE.Chloroform (150 rrLl) was further added thereto, and the mixture was refluxed for 5 hours.

次いで、トルエン(100−×2)を加え、減EE濃縮
し、残渣に乾燥エーテルを加え、析出した固体を濾取し
た。
Next, toluene (100-x2) was added, and the mixture was concentrated under reduced EE. Dry ether was added to the residue, and the precipitated solid was collected by filtration.

固体は乾燥エーテルで洗浄後、メタノール乾燥エーテル
にて再結晶し五酸化リン上室温で12時間乾燥した。
The solid was washed with dry ether, recrystallized with methanol dry ether, and dried over phosphorous pentoxide at room temperature for 12 hours.

収量42g(86%) 融点132°〜135°C Ca)’d −12,0(C=3 、ピリジン)4)
Boc−L−Gin−D−Arg(NO2)−0Bzl
の合成 に、Hofmann et al (J 、Ame r
、 chem。
Yield: 42 g (86%) Melting point: 132° to 135°C Ca)'d -12,0 (C=3, pyridine) 4)
Boc-L-Gin-D-Arg(NO2)-0Bzl
For the synthesis of Hofmann et al.
, chem.

Soc、、87,620(1965))の方法により得
たBoc−L−GIn(5,09,20m mol)と
D −Arg (NO□) −0Bz 1 ・2Tos
OH(13,1g 、20mmol)をDMF−THF
(5TrLl〜20TLl)に懸濁し、−10℃に冷却
後、トリエチルアミン(2,F3rnl 、 20 m
mol) 1−ハイドロキシベンツトリアゾール(2,
7g、20mmol)WSCI (3,6rul、 2
0 m mo l )を順次加え、−10℃で1時間、
次いで室温で16時間攪拌した。
Soc, 87, 620 (1965)) Boc-L-GIn (5,09,20 mmol) and D -Arg (NO□) -0Bz 1 ・2Tos
OH (13.1g, 20mmol) in DMF-THF
(5TrLl to 20TLl), and after cooling to -10°C, triethylamine (2,F3rnl, 20 m
mol) 1-hydroxybenztriazole (2,
7g, 20mmol) WSCI (3,6rul, 2
0 mmol) was added sequentially and incubated at -10°C for 1 hour.
The mixture was then stirred at room temperature for 16 hours.

反応終了後、THFを減圧留去し、残渣をクロロホルム
(300rn0に溶解し、lN塩酸(l O0TLlX
3 )、水(100mO110%炭酸ナトリウム水溶
液(100就×3)、水(io。
After the reaction, THF was distilled off under reduced pressure, and the residue was dissolved in chloroform (300rn0) and 1N hydrochloric acid (100TL1X
3), water (100 mO 110% aqueous sodium carbonate solution (100 x 3), water (io.

献×2)で洗浄した。Washed with water (2).

次いで、クロロホルムを減圧留去し残渣にエーテルを加
え、析出した結晶を濾取した。
Next, chloroform was distilled off under reduced pressure, ether was added to the residue, and the precipitated crystals were collected by filtration.

結晶は水、エーテルで洗浄し、メタノール−エーテルよ
り再結晶し、五酸化リン上室温にて12時間減圧乾燥し
た。
The crystals were washed with water and ether, recrystallized from methanol-ether, and dried under reduced pressure over phosphorus pentoxide at room temperature for 12 hours.

5)Boc−L−11e−L−Ala−Gly−OEt
の合成M、Bergman et al(J、Bi
ol、Chem、。
5) Boc-L-11e-L-Ala-Gly-OEt
Synthesis of M, Bergman et al (J, Bi
ol,Chem,.

109.325.(1935))の方法により得たZ−
L−Ala −Gly −OE t(12,4g、 4
0m mo l)に冷却下25%臭化水素酢酸溶液50
縦を加え、室温で1時間攪拌した。
109.325. (1935))
L-Ala-Gly-OEt(12.4g, 4
0 m mol) of 25% hydrogen bromide acetic acid solution under cooling.
The mixture was added vertically and stirred at room temperature for 1 hour.

上記溶液にエーテルを加えると固体が析出した。When ether was added to the above solution, a solid precipitated.

その固体をエーテルで洗浄し、水酸化ナトリウム上減圧
乾燥をした。
The solid was washed with ether and dried under reduced pressure over sodium hydroxide.

次に、得られた固体をDMF30−に溶解し、冷却下ト
リエチルアミンでpH7〜7.5としN−t−ブチルオ
キシカルボニル−L−イソロイシンのN−ハイドロキシ
コハク酸イミドエステル14.4 Fi (44mmo
l)を加え室温で24時間攪拌した。
Next, the obtained solid was dissolved in DMF30- and adjusted to pH 7 to 7.5 with triethylamine under cooling.
1) was added and stirred at room temperature for 24 hours.

反応溶液に水200TrLlを加え、酢酸エチル(20
0TLl、 150ml!、100mOで3回抽出し
、有機層をlN塩酸、水:5%重炭酸水素ナトリウム水
溶液で順次洗浄後、脱水硫酸マグネシウムで乾燥した。
200TrLl of water was added to the reaction solution, and ethyl acetate (200TrLl) was added to the reaction solution.
0TLl, 150ml! , 100 mO three times, and the organic layer was washed successively with 1N hydrochloric acid, water: 5% aqueous sodium bicarbonate solution, and dried over dehydrated magnesium sulfate.

酢酸エチルを減圧留去し、残渣にエーテルを加えると結
晶が析出した、結晶を濾取し、酢酸エチル−エーテルよ
り再結晶し、五酸化リン上室でv2時間減減圧燥した。
Ethyl acetate was distilled off under reduced pressure, and ether was added to the residue to precipitate crystals. The crystals were collected by filtration, recrystallized from ethyl acetate-ether, and dried under reduced pressure in a room above phosphorus pentoxide for 2 hours.

収量13.1(84%) 融点148.5°−149°C (a ”g” −50,9,’ (C=2.2 、
エタノール)元素分析 CHN% 計算f直(C18H3□06N8として) 55.7
98.5810.85分析値 55
.548.7410.806) Boc−L−I 1e
−L−Ala−L−Gly−OHの合成 Boc−LI 1e−L−Ala−Gly−OEt (
3,99、10m mol ) をジオキサン20rI
Llに溶かし、冷却下攪拌しつつIN水酸化ナトリウム
(I LmlSl 1m mol) を滴下し、更に
室温で1時間攪拌した。
Yield 13.1 (84%) Melting point 148.5°-149°C (a "g"-50,9,' (C=2.2,
Ethanol) Elemental analysis CHN% Calculation directly (as C18H3□06N8) 55.7
98.5810.85 Analysis value 55
.. 548.7410.806) Boc-L-I 1e
Synthesis of -L-Ala-L-Gly-OH Boc-LI 1e-L-Ala-Gly-OEt (
3,99,10m mol) in dioxane 20rI
IN sodium hydroxide (ILmlSl 1 mmol) was added dropwise while stirring under cooling, and the mixture was further stirred at room temperature for 1 hour.

次いで、反応液をlN塩酸で中和し、ジオキサンを減圧
留去した。
Next, the reaction solution was neutralized with 1N hydrochloric acid, and dioxane was distilled off under reduced pressure.

水層をlN塩酸でpH2とし、酢酸エチル(looTL
l。
The aqueous layer was adjusted to pH 2 with 1N hydrochloric acid, and ethyl acetate (looTL
l.

50m0で2回抽出し、有機層を飽和食塩水で洗浄し、
無水硫酸ナトリウムで乾燥した。
Extracted twice at 50 mO, washed the organic layer with saturated saline,
It was dried with anhydrous sodium sulfate.

酢酸エチルを減圧留去し、残渣にエーテルを加えると結
晶が析出した。
Ethyl acetate was distilled off under reduced pressure, and ether was added to the residue to precipitate crystals.

結晶を濾取し、酢酸エチル−エーテルより再結晶し、五
酸化リン上室温で12時間減減圧燥した。
The crystals were collected by filtration, recrystallized from ethyl acetate-ether, and dried under reduced pressure over phosphorus pentoxide at room temperature for 12 hours.

7) Boc−LI le−L−Ala−Gly−L
−Gln−D−Arg (NO2) −0Bz lの合
成Boc−L−Gl n−D−Arg (NO2) −
0Bz l(5,59,10m mol)に冷却下トリ
フルオル酢酸(20mJ)を加え、更に冷却下に5分間
、次いで室温にて45分間攪拌した。
7) Boc-LI le-L-Ala-Gly-L
-Gln-D-Arg (NO2) -0Bz l synthesis Boc-L-Gl n-D-Arg (NO2) -
Trifluoroacetic acid (20 mJ) was added to 0Bzl (5,59,10 mmol) under cooling, and the mixture was further stirred for 5 minutes under cooling and then for 45 minutes at room temperature.

次いで、冷却下6N塩酸/ジオキサン(1,7m7!、
10m mol)を加え、過剰のトルフルオル酢酸を
減圧留去し、残渣にエーテルを加えると固体が析出した
Then, 6N hydrochloric acid/dioxane (1.7 m7!,
10 mmol) was added, excess trifluoroacetic acid was distilled off under reduced pressure, and ether was added to the residue to precipitate a solid.

析出固体をエーテルにて洗浄し、水酸化ナトリウム上に
て減匡乾燥した。
The precipitated solid was washed with ether and dried over sodium hydroxide.

得らレタ固体をDMF −THF (10yd〜30r
fLl)に溶解し、−10℃に冷却しN−メチルモルホ
リンにてpH5に調整後、Boc−L−Ile−L−A
la−Gly−OH(3,6g、10mmol)l−ハ
イドロキシベンツトリアゾール(:l。
The obtained lettuce solid was dissolved in DMF-THF (10yd~30r
fLl), cooled to -10°C and adjusted to pH 5 with N-methylmorpholine.
la-Gly-OH (3.6 g, 10 mmol) l-hydroxybenztriazole (:l.

15mmol)、WSCI (2,7ml、15m
molを順次加え、−1O℃で1時間、次いで室温で1
6時間攪拌した。
15mmol), WSCI (2.7ml, 15m
1 mol was added sequentially at -1O℃ for 1 hour, then at room temperature for 1 hour.
Stirred for 6 hours.

反応終了後、THFを減圧留去し、残渣にIN塩酸(t
ooml)を加え、得られた固体を濾取し、水、5%炭
酸水素ナトリウム、水、エーテルにて洗浄後、DMF−
メタノールに加温下に懸濁した。
After the reaction, THF was distilled off under reduced pressure, and the residue was added with IN hydrochloric acid (t
The resulting solid was collected by filtration, washed with water, 5% sodium hydrogen carbonate, water, and ether, and then DMF-
It was suspended in methanol under heating.

酢酸エチルを加え、析出した固体を濾取し、五酸化リン
上室温にて12時間減減圧燥した。
Ethyl acetate was added, and the precipitated solid was collected by filtration and dried under reduced pressure over phosphorus pentoxide at room temperature for 12 hours.

8)Boc−L−Pro−L−Gin−Gly−L−1
1e−L−Ala−Gly−L−Gin−D−Arg
(NO2)−OBzlの合成 Boc−L−Ile−L−Ala−Gly−L−Gln
−D−Arg(NO2)−0Bzl (1,2El 、
1.5m mol)に冷却下にトリフルオロ酢酸(1
5mAりを加え、その後室温で1時間攪拌した。
8) Boc-L-Pro-L-Gin-Gly-L-1
1e-L-Ala-Gly-L-Gin-D-Arg
Synthesis of (NO2)-OBzl Boc-L-Ile-L-Ala-Gly-L-Gln
-D-Arg(NO2)-0Bzl (1,2El,
trifluoroacetic acid (1.5 mmol) under cooling.
5 mA was added, and the mixture was stirred at room temperature for 1 hour.

薄層クロマトグラフィーで反応が終了したのを確認した
後、トリフルオロ酢酸を減圧下に留去し、残渣にエーテ
ルを加えて混練し、エーテルはデカントして除いた。
After confirming the completion of the reaction by thin layer chromatography, trifluoroacetic acid was distilled off under reduced pressure, ether was added to the residue and kneaded, and the ether was removed by decantation.

同様の操作を2回繰り返した後、固体を水酸化ナトリウ
ム上減圧乾燥した。
After repeating the same operation twice, the solid was dried under reduced pressure over sodium hydroxide.

得られた固体を6TrLlのDMFに溶解し、Boc−
L−Pr。
The obtained solid was dissolved in 6TrLl DMF and Boc-
L-Pr.

−L−Gl n−G1 y−OH(0,6g、 1.5
m mol)1−ヒドロキシベンツトリアゾール(0
,:l。
-L-Gl n-G1 y-OH (0.6 g, 1.5
m mol) 1-hydroxybenztriazole (0
, :l.

2、25 m mol)を加えた。2.25 mmol) was added.

冷却下にWSCI(0,477171!、 2.25
m mol)を加え、そのまま1時間更に室温で1夜攪
拌した。
WSCI (0,477171!, 2.25 under cooling)
m mol) was added thereto, and the mixture was stirred for 1 hour and then at room temperature overnight.

反応液にエーテルを加えて固体を析出させ、濾取した。Ether was added to the reaction solution to precipitate a solid, which was collected by filtration.

得られた固体を水、IN−塩酸、水、酢酸エチルの順に
洗浄した。
The obtained solid was washed successively with water, IN-hydrochloric acid, water, and ethyl acetate.

9)NABS−L−Pro−L−Gln−Gly−L−
11e−L−Al a−Gly−L−Gln −D−A
rg−OHの合成 Boc−L−Pro −L−Gl n−G1 y−L−
I le −L−Ala −Gl y−L−Gin−D
−Arg (NO2) −OB z l (300m9
.0.28m mol )にアニソール(0,5m1)
を加え、次いで0℃で弗化水素(7ml)を加え1時間
反応した。
9) NABS-L-Pro-L-Gln-Gly-L-
11e-L-Al a-Gly-L-Gln -D-A
Synthesis of rg-OH Boc-L-Pro -L-Gl n-G1 y-L-
I le -L-Ala -Gly-L-Gin-D
-Arg (NO2) -OB z l (300m9
.. Anisole (0.5 ml) in 0.28 m mol
was added thereto, and then hydrogen fluoride (7 ml) was added at 0°C and the mixture was reacted for 1 hour.

余剰の弗化水素を減圧下に留去し、残渣にエーテルを加
えて混練して固体とし、エーテルはデカントして除いた
Excess hydrogen fluoride was distilled off under reduced pressure, ether was added to the residue and kneaded to form a solid, and the ether was removed by decantation.

同様の操作を2回繰り返した後、水酸化ナトリウム上減
圧乾燥した。
After repeating the same operation twice, it was dried under reduced pressure over sodium hydroxide.

得られた固体を50%酢酸水溶液に溶解し、’ D o
wexl X 2 (アセテート型)に通じ、同溶媒で
流し出した。
The obtained solid was dissolved in a 50% aqueous acetic acid solution and 'D o
It was passed through a Wexl X 2 (acetate type) and flushed out with the same solvent.

流出液を減圧下に濃縮乾固し、残渣に5TLlの水を加
えて溶解し、炭酸水素ナトリウム(110rn9.1.
3mmol)を加え、冷却下にp−(4−ヒドロキシ−
■−ナフチルアソ)ベンゼンスルフォニルクロライド(
240m9.0.7m mol )をTHF5TLlに
溶解したものを加えた。
The effluent was concentrated to dryness under reduced pressure, the residue was dissolved in 5TLl of water, and sodium hydrogen carbonate (110rn9.1.
3 mmol) and p-(4-hydroxy-
■-Naphthylaso)benzenesulfonyl chloride (
A solution of 240m9.0.7mmol) dissolved in THF5TL1 was added.

その後、室温で3時間攪拌した。Thereafter, the mixture was stirred at room temperature for 3 hours.

反応液を減圧下に濃縮してTHFを除き、水層は酢酸エ
チルを加えて未反応のp−(4−ヒドロキシ−l−ナフ
チルアゾ)ベンゼンスルフォニルクロライドを抽出して
除いた。
The reaction solution was concentrated under reduced pressure to remove THF, and the aqueous layer was extracted with ethyl acetate to remove unreacted p-(4-hydroxy-l-naphthylazo)benzenesulfonyl chloride.

次に、水溶液は大量の水にて希釈した後、ハイポーラス
樹脂(DIAION HP−20)に通じた。
Next, the aqueous solution was diluted with a large amount of water, and then passed through a high porous resin (DIAION HP-20).

樹脂を大量の水で洗浄した後、90%メタノール水溶液
で溶出した。
After washing the resin with a large amount of water, it was eluted with a 90% methanol aqueous solution.

溶出液を減圧下に濃縮乾固し、残渣に50%酢酸水溶液
を加えて溶解し、Dowex I X 2 (アセテー
ト型)に通じ50%酢酸水溶液で流出した。
The eluate was concentrated to dryness under reduced pressure, and the residue was dissolved in 50% acetic acid aqueous solution, passed through Dowex IX2 (acetate type), and eluted with 50% acetic acid aqueous solution.

流出液は減圧下に濃縮乾固し、残渣に酢酸エチルを加え
て赤色固体を得た。
The effluent was concentrated to dryness under reduced pressure, and ethyl acetate was added to the residue to obtain a red solid.

収量 190■(57%) 融点(分解点) 230°〜239℃ 実施例 2 PAB−L−P ro−L−Gln−Gly−L−I
1e−L−Ala −Gly −L−Gin −D−A
rg−OHの合成1)PAB−L−Pro−L−Gin
−Gly−OHの合成L−Pro−L−GIn−Gly
−OH(400■、1.3mmol) を5TLlの
水に溶解し、炭酸水素ナトリウム(220mtjl、
2.6mmol)を加え、冷却下に、p−フェニルアゾ
ベンジルクロライド(320m9 、1.3 m mo
l )を5mlのTHFに溶解したものを加え、その後
室温で3時間攪拌した。
Yield 190■ (57%) Melting point (decomposition point) 230° to 239°C Example 2 PAB-L-Pro ro-L-Gln-Gly-L-I
1e-L-Ala -Gly -L-Gin -D-A
Synthesis of rg-OH 1) PAB-L-Pro-L-Gin
-Synthesis of Gly-OH L-Pro-L-GIn-Gly
-OH (400 μl, 1.3 mmol) was dissolved in 5 TLl of water, and sodium hydrogen carbonate (220 mtjl,
2.6 mmol) was added, and under cooling, p-phenylazobenzyl chloride (320 m9, 1.3 m mo
1) dissolved in 5 ml of THF was added, followed by stirring at room temperature for 3 hours.

反応液を減匡下に濃縮してTHFを留去した後、IN−
塩酸で水溶液のpHを2とし、酢酸エチルを加え抽出し
た。
After concentrating the reaction solution while reducing the volume and distilling off THF, IN-
The pH of the aqueous solution was adjusted to 2 with hydrochloric acid, and ethyl acetate was added for extraction.

酢酸エチル層は飽和食塩水で洗浄し、芒硝で乾燥した。The ethyl acetate layer was washed with saturated brine and dried over Glauber's salt.

芒硝を除去した後、減匡下に濃縮乾固し、残渣をメタノ
ール−エーテルから再沈澱した。
After removing Glauber's salt, the mixture was concentrated to dryness under reduced volume, and the residue was reprecipitated from methanol-ether.

収量 360■(53□) 融点(分解点)1898〜194℃ (a)28 −2.0°(C=0.5.DMF)元
素分析 CHN% 計算値 55.605.8815.5
6(C25H280e No・7H20として)分析値
55.615.4815.332
)PAB−L−Pro−L−Gln−Gly−L−11
e−L−Ala −Gly−L−Gin−D−Arg
(No2) −0Bzlの合成 りoc −L−I 1e−L−Ala −Gl y−L
−Gl n−D−Arg(NO2)−0Bzl (20
0771、0,26mmol)に冷却下にトリフルオロ
酢酸を加え、室温で1時間攪拌した。
Yield 360■ (53□) Melting point (decomposition point) 1898-194℃ (a) 28 -2.0° (C=0.5.DMF) Elemental analysis CHN% Calculated value 55.605.8815.5
6 (as C25H280e No.7H20) Analysis value
55.615.4815.332
)PAB-L-Pro-L-Gln-Gly-L-11
e-L-Ala-Gly-L-Gin-D-Arg
(No. 2) Synthesis of -0Bzl oc -L-I 1e-L-Ala -Gly-L
-Gl n-D-Arg(NO2)-0Bzl (20
Trifluoroacetic acid was added to the solution (0771, 0.26 mmol) under cooling, and the mixture was stirred at room temperature for 1 hour.

薄層クロマトグラフィーで反応が終了したのを確認した
後、余剰のトリフルオロ酢酸を減匡下に留去し、残渣に
エーテルを加え混練して固体とし、エーテルはデカント
して除いた。
After confirming the completion of the reaction by thin layer chromatography, excess trifluoroacetic acid was distilled off under reduced volume, ether was added to the residue and kneaded to form a solid, and the ether was removed by decantation.

同様の操作を2回続けた後、固体は水酸化ナトリウム上
減圧乾燥した。
After repeating the same operation twice, the solid was dried under reduced pressure over sodium hydroxide.

得られた固体を311LlのDMFに溶解し、PAB−
L−Pro−L−Gln−Gly−OH(130m1i
l 、 0.26 m mol)l−ヒドロキシベンツ
トリアゾール(70■。
The obtained solid was dissolved in 311 Ll of DMF and PAB-
L-Pro-L-Gln-Gly-OH (130m1i
l, 0.26 mmol) l-hydroxybenztriazole (70 ■.

0、52 m mol)を加え、冷却下にWSCI(0
,1ml、0.52mmol)を加え、1時間攪拌した
WSCI (0.52 mmol) was added under cooling.
, 1 ml, 0.52 mmol) and stirred for 1 hour.

更にその後室温でl夜攪拌した。Thereafter, the mixture was stirred at room temperature for one night.

反応液にエーテルを加えて固体を濾取し、水、lN塩酸
水、酢酸エチルの順に洗浄した。
Ether was added to the reaction solution, and the solid was collected by filtration and washed successively with water, 1N aqueous hydrochloric acid, and ethyl acetate.

収量 230Tn9(75%) 3)PAB−L−Pro−L−Gin−Gly−L−1
1e−L−Ala−Gly−L−Gl n−D−Arg
−OHの合成 PAB−L−Pro−L−Gln−L−I 1e−L−
AlaGly−L−Gln −D−Arg (NO2)
−0B z l (2001119、0,17m
mol)にアニソール0.5mlを加え、o’cで弗化
水素7TILlで1時間反応した。
Yield 230Tn9 (75%) 3) PAB-L-Pro-L-Gin-Gly-L-1
1e-L-Ala-Gly-L-Gl n-D-Arg
Synthesis of -OH PAB-L-Pro-L-Gln-L-I 1e-L-
AlaGly-L-Gln-D-Arg (NO2)
-0Bz l (2001119, 0,17m
mol) was added to 0.5 ml of anisole, and the mixture was reacted with 7 TIL of hydrogen fluoride for 1 hour at o'c.

余剰の弗化水素を減モ下に留去し残渣にエーテルを加え
て固体としエーテルはデカントして除いた。
Excess hydrogen fluoride was distilled off under reduced pressure, and ether was added to the residue to make it solid, and the ether was removed by decantation.

同様の操作を2回繰り返し、得られた固体は、水酸化ナ
トリウム上減圧下に乾燥した。
The same operation was repeated twice, and the obtained solid was dried under reduced pressure over sodium hydroxide.

この固体を50%酢酸水溶液に溶解し、 −、Dowe
xl×2(アセテート型)に通じ、50%酢酸水溶液で
流出させた。
This solid was dissolved in 50% acetic acid aqueous solution, -, Dowe
xl x 2 (acetate type) and eluted with 50% acetic acid aqueous solution.

流出液は減圧下に濃縮乾固し残渣に酢酸エチルを加えて
橙色固体を得た。
The effluent was concentrated to dryness under reduced pressure, and ethyl acetate was added to the residue to obtain an orange solid.

収量 1501n9(80%) 融点(分解点) 1968〜205℃ (a)背−−34,9゜ (C=0.4 、50%酢酸水溶吻 実施例 3 基質としてNABS−L−Pro−L−Ala−Gly
−L−11e−L−Ala−Gly−L−Gln−D−
Arg−OHを用い基質濃度が5X10”−’Mとなる
様に20%エタノール −0,05Mトリス塩酸緩衝液
(pH7,8、0,15M NaC1,5mM Ca
C12fi有)に溶解した。
Yield 1501n9 (80%) Melting point (decomposition point) 1968-205°C (a) Back -34.9° (C = 0.4, 50% acetic acid aqueous solution Example 3 NABS-L-Pro-L- as substrate Ala-Gly
-L-11e-L-Ala-Gly-L-Gln-D-
Using Arg-OH, 20% ethanol-0.05M Tris-HCl buffer (pH 7.8, 0.15M NaCl, 5mM Ca
C12fi).

上記基質溶液0.511Llに緩衝液で稀釈した精製コ
ラゲナーゼ(17,4units 7ml ) 0.1
−を添加し反応を開始した。
Purified collagenase (17.4 units 7ml) diluted with buffer in 0.511L of the above substrate solution 0.1
- was added to start the reaction.

60分後、反応液に0.1rfllの5N塩酸を加え酵
素反応を停止させた。
After 60 minutes, 0.1 rfull of 5N hydrochloric acid was added to the reaction solution to stop the enzyme reaction.

次いで酢酸エチル1mlを加えてNABS含有疎水性分
解物を抽出した。
Next, 1 ml of ethyl acetate was added to extract the NABS-containing hydrophobic decomposition product.

遠心機を用いて3,000〜5.000 rpm 10
分間室温で遠心分離し、有機層を0.5−セルに分取し
389 nmに於ける吸光度を測定し酵素活披を測定し
た、その結果活性はOD 389/ hr/mA’=0
.100であった。
3,000-5.000 rpm using a centrifuge 10
After centrifugation at room temperature for minutes, the organic layer was separated into a 0.5-cell and the absorbance at 389 nm was measured to determine the enzyme activity.As a result, the activity was OD 389/hr/mA'=0
.. It was 100.

実施例 4 基質とじPAB−L−Pro−L−Ala−C1y−L
−Lle−L−Ala−Gly−L−Gln−D−Ar
g−OHを用い基質濃度が5X10−’Mとなる様に0
.05Mトリス塩酸緩衝液(pH7,8、0,15M
NaC1。
Example 4 Substrate binding PAB-L-Pro-L-Ala-C1y-L
-Lle-L-Ala-Gly-L-Gln-D-Ar
Using g-OH, the substrate concentration was 5 x 10-'M.
.. 05M Tris-HCl buffer (pH 7.8, 0.15M
NaC1.

5mM CaCl2含有)に溶解した。(containing 5mM CaCl2).

上記基質溶液0.1 mlに緩衝液で稀釈した精製コラ
ゲナーゼ0.1 mlを添加し反応を開始した。
0.1 ml of purified collagenase diluted with a buffer solution was added to 0.1 ml of the above substrate solution to start the reaction.

60分後、反応液にIN塩酸0.5 rrLlを加え反
応を停止させた。
After 60 minutes, 0.5 rrLl of IN hydrochloric acid was added to the reaction solution to stop the reaction.

次いで、食塩を加え飽和させた後PAB含有疎水性分解
物を酢酸エチル1TILlにて抽出、以後実施例3と同
様に処理し、325nmに於ける吸光度を測定した。
Next, after adding sodium chloride to saturation, the PAB-containing hydrophobic decomposition product was extracted with 1 TIL of ethyl acetate, and thereafter treated in the same manner as in Example 3, and the absorbance at 325 nm was measured.

Claims (1)

【特許請求の範囲】 1一般式 %式% (但し、Xはp−(4−ヒドロキシ−1−ナフチルアゾ
)ベンゼンスルフォニル基またはp−フェニルアゾベン
ゾイル基を、OHはC−末端が遊離カルボキシル基であ
ることを、Pro、Gln。 Gly 、 I le 、 AlaおよびArgはそれ
ぞれプロリン、グルタミン、グリシン、イソロイシン、
アラニンおよびアルギニン残基を示す。 )で示されるペプチド誘導体。 2一般式 %式% ((但し、Xはp−(4−ヒドロキシ−■−ナフチルア
ゾ)ベンゼンスルフォニル基またはp−フェニルアゾベ
ンゾイル基を、OHはC−末端が遊離カルボキシル基で
あることを、Pro、Gln。 Gly 、 I le 、 Al aおよびArgはそ
れぞれプロリン、グルタミン、グリシン、イソロイシン
、アラニンおよびアルギニン残基を示す。 ))で示されるオクタペプチド遊導体とコラゲナーゼ含
有試料とを水性溶夜中にて接触せしめ、次いで遊離生成
するX−L−Pro−L−Gln−Gly−OHを定量
することを特徴とするコラゲナーゼ活性の測定方法。
[Claims] 1 General formula % Formula % (wherein, Pro, Gln. Gly, Ile, Ala and Arg are respectively proline, glutamine, glycine, isoleucine,
Alanine and arginine residues are shown. ) Peptide derivatives shown. 2 General formula % Formula % ((However, , Gln. Gly, Ile, Ala and Arg represent proline, glutamine, glycine, isoleucine, alanine and arginine residues, respectively. 1. A method for measuring collagenase activity, which comprises contacting and then quantifying XL-Pro-L-Gln-Gly-OH that is released.
JP10350576A 1976-01-24 1976-08-30 Method for measuring collagenase activity using peptide nodule and peptide derivative Expired JPS5843389B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP10350576A JPS5843389B2 (en) 1976-08-30 1976-08-30 Method for measuring collagenase activity using peptide nodule and peptide derivative
SE7700582A SE431201B (en) 1976-01-24 1977-01-20 FOR USE IN SATURDING OF COLLAGENA ACTIVITY PROVIDED PEPTIDE DERIVATIVE EQUIPMENT
US05/761,020 US4138394A (en) 1976-01-24 1977-01-21 Peptide derivatives and a method of measuring collagenase activity
DE19772702699 DE2702699A1 (en) 1976-01-24 1977-01-24 NEW PEPTIDE DERIVATIVES AND METHODS OF MEASURING COLLAGENASE ACTIVITY USING THESE COMPOUNDS
US05/853,302 US4176009A (en) 1976-01-24 1977-11-21 Method of measuring collagenase activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10350576A JPS5843389B2 (en) 1976-08-30 1976-08-30 Method for measuring collagenase activity using peptide nodule and peptide derivative

Publications (2)

Publication Number Publication Date
JPS5328165A JPS5328165A (en) 1978-03-16
JPS5843389B2 true JPS5843389B2 (en) 1983-09-27

Family

ID=14355827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10350576A Expired JPS5843389B2 (en) 1976-01-24 1976-08-30 Method for measuring collagenase activity using peptide nodule and peptide derivative

Country Status (1)

Country Link
JP (1) JPS5843389B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374765A (en) * 1981-10-07 1983-02-22 American Home Products Corporation Mammalian collagenase inhibitors
JPH01213232A (en) * 1988-02-22 1989-08-28 Fuji Yakuhin Kogyo Kk Novel remedy for dermal ulcer

Also Published As

Publication number Publication date
JPS5328165A (en) 1978-03-16

Similar Documents

Publication Publication Date Title
US5055451A (en) Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
EP0004256B1 (en) Easily split substrates for the quantification of proteases, a process for their production and a method for the quantification of proteases
US4214049A (en) Assay of serine proteases using novel chromogenic enzyme substrates
JPS61189298A (en) Novel oligopeptidylargininol derivative
US4138394A (en) Peptide derivatives and a method of measuring collagenase activity
WO1996021740A1 (en) Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
JPS6126558B2 (en)
US4631270A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
DK145799B (en) TRIPEPTIDES OR SALTS THEREOF USED AS DIAGNOSTIC CHROMOGENT SUBSTRATE WITH HIGH SPECIFICITY ABOVE THROMBIN AND THROMBIN SIMILAR ENZYMES
JPS5843389B2 (en) Method for measuring collagenase activity using peptide nodule and peptide derivative
JPS6220200B2 (en)
US4569907A (en) Thiopeptolide substrates for vertebrate collagenase
DK168574B1 (en) Peptide derivatives and salts thereof with mineral or organic acids and their use as a substrate for the quantitative determination of C1 esterase
JPH049800B2 (en)
JPS5828867B2 (en) New tetrapeptide derivatives
WO2020125045A1 (en) Method for synthesizing romidepsin
JPH0360837B2 (en)
JP3009718B2 (en) New peptides, their production methods and applications
Dong et al. Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2
HU180787B (en) Process for preparing peptides containing cysteine
JP3009719B2 (en) New peptides, their production methods and applications
JP3012291B2 (en) Novel peptide, its production method and use
US4596675A (en) Novel thiopeptolide substrates for vertebrate collagenase
JP3009720B2 (en) New peptides, their production methods and applications
JP2965683B2 (en) Novel peptide, method for producing it and use